Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-076986
Filing Date
2017-03-09
Accepted
2017-03-09 16:46:17
Documents
85
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d323687d10k.htm 10-K 1024719
2 EX-21.1 d323687dex211.htm EX-21.1 2524
3 EX-23.1 d323687dex231.htm EX-23.1 2900
4 EX-31.1 d323687dex311.htm EX-31.1 6550
5 EX-31.2 d323687dex312.htm EX-31.2 6589
6 EX-32.1 d323687dex321.htm EX-32.1 3858
7 EX-32.2 d323687dex322.htm EX-32.2 4103
14 GRAPHIC g323687g66x31.jpg GRAPHIC 37789
  Complete submission text file 0001193125-17-076986.txt   8799526

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT casc-20161231.xml EX-101.INS 2200884
9 XBRL TAXONOMY EXTENSION SCHEMA casc-20161231.xsd EX-101.SCH 84031
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casc-20161231_cal.xml EX-101.CAL 44547
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casc-20161231_def.xml EX-101.DEF 590653
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE casc-20161231_lab.xml EX-101.LAB 470918
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casc-20161231_pre.xml EX-101.PRE 619176
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33882 | Film No.: 17679037
SIC: 8731 Services-Commercial Physical & Biological Research